Innoviva (NASDAQ:INVA) moves above its long-term average, drawing renewed attention across biotechnology-focused equities. Strong quarterly performance and royalty-driven model strengthen financial ...
The White House said Friday it’s adding three drugs for diabetes and lung disease to the self-pay platform TrumpRx, as the administration works to expand the site as part of its push to lower drug pri ...
Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.
March 20 (Reuters) - The U.S. Food and Drug Administration on Friday approved Bristol Myers Squibb's combination treatment ...
ForaCare’s integration with athenahealth’s Marketplace streamlines provider access to scalable RPM, CCM, and RTM ...
The FDA has approved the combination of nivolumab plus chemotherapy as first-line treatment for certain patients with stage III or IV classical Hodgkin lymphoma.The approval, for individuals aged 12 ...
Immunomodulatory approaches such as GRI-0621 (RARβγ agonist targeting iNKT activity) may support alveolar basement membrane repair and provide complementary biology for oral combination regimens.
Annual Meeting, James Song, MD, chief medical officer and director of clinical research, Frontier Dermatology, outlines maj ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results